HONG KONG--(Marketwire -06/07/12)- This morning, www.MarketFoundations.com announced new reports highlighting Celgene Corporation (CELG) and TW Telecom Inc (TWTC). Free research downloads are available at www.MarketFoundations.com/index.php?coa=CELG&cob=TWTC.
With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Market Foundations is releasing new coverage on Celgene Corporation for its current position within the healthcare industry. Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. The full research report on Celgene Corporation (CELG) is available here: www.MarketFoundations.com/index.php?coa=CELG.
Market Foundations has released research on TW Telecom Inc for its changing role within the technology industry. The full research report on TW Telecom Inc (TWTC) is available here: www.MarketFoundations.com/index.php?cob=TWTC.
About Market Foundations
By providing members with financial information services, we provide the foundation investors need to build investing intelligence. The difference between consistently making good investments or bad investments is nothing more than the right information at the right time.
- Celgene Corporation